Pure Global AI
ANVISA registration 81816720087Valid until Jan 05, 2036

TRYPANOSOMA CRUZI

ANVISA Registration Number: 81816720087ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDAVIRCELL S.L.Risk Class IV
Verified
Device names
Technical name
TRYPANOSOMA CRUZI
View exact technical-name matches →
Commercial name
CHAGAS VIRCLIA® IgG+IgM MONOTEST
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
81816720087
Process Number
25351462676202410
CNPJ
31167508000102
Company information
Registration Holder
ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA
Manufacturer
VIRCELL S.L.
Manufacturing Country
Spain
PT: ESPANHA
Dates and status
Publication Date
Jan 05, 2026
Validity
05/01/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for TRYPANOSOMA CRUZI in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81816720087 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until Jan 05, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.